vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与Rimini Street, Inc.（RMNI）财务数据对比。点击上方公司名可切换其他公司
Rimini Street, Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.4倍（$105.5M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 1.2%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 1.1%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
Rimini Street是一家全球企业软件第三方支持服务提供商，主要为甲骨文、SAP等厂商的企业级软件产品提供高性价比的维护、技术支持与咨询解决方案，服务覆盖全球各行业客户，助力企业降低运营成本。
PBYI vs RMNI — 直观对比
营收规模更大
RMNI
是对方的1.4倍
$75.5M
营收增速更快
PBYI
高出26.5%
1.2%
两年增速更快
PBYI
近两年复合增速
1.1%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $105.5M |
| 净利润 | — | $1.4M |
| 毛利率 | 69.3% | 59.0% |
| 营业利润率 | 22.7% | 4.6% |
| 净利率 | — | 1.3% |
| 营收同比 | 27.7% | 1.2% |
| 净利润同比 | — | -59.4% |
| 每股收益（稀释后） | $0.26 | $0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYIRMNI
| Q1 26 | — | $105.5M | ||
| Q4 25 | $75.5M | $109.8M | ||
| Q3 25 | $54.5M | $103.4M | ||
| Q2 25 | $52.4M | $104.1M | ||
| Q1 25 | $46.0M | $104.2M | ||
| Q4 24 | $59.1M | $114.2M | ||
| Q3 24 | $80.5M | $104.7M | ||
| Q2 24 | $47.1M | $103.1M |
净利润PBYIRMNI
| Q1 26 | — | $1.4M | ||
| Q4 25 | — | $724.0K | ||
| Q3 25 | $8.8M | $2.8M | ||
| Q2 25 | $5.9M | $30.3M | ||
| Q1 25 | $3.0M | $3.4M | ||
| Q4 24 | — | $6.7M | ||
| Q3 24 | $20.3M | $-43.1M | ||
| Q2 24 | $-4.5M | $-1.1M |
毛利率PBYIRMNI
| Q1 26 | — | 59.0% | ||
| Q4 25 | 69.3% | 60.4% | ||
| Q3 25 | 77.7% | 59.9% | ||
| Q2 25 | 76.5% | 60.4% | ||
| Q1 25 | 77.1% | 61.0% | ||
| Q4 24 | 76.4% | 63.7% | ||
| Q3 24 | 63.9% | 60.7% | ||
| Q2 24 | 77.4% | 59.1% |
营业利润率PBYIRMNI
| Q1 26 | — | 4.6% | ||
| Q4 25 | 22.7% | 4.5% | ||
| Q3 25 | 17.6% | 4.2% | ||
| Q2 25 | 12.7% | 39.6% | ||
| Q1 25 | 8.7% | 9.0% | ||
| Q4 24 | 22.6% | 13.0% | ||
| Q3 24 | 27.4% | -47.4% | ||
| Q2 24 | -4.6% | -0.8% |
净利率PBYIRMNI
| Q1 26 | — | 1.3% | ||
| Q4 25 | — | 0.7% | ||
| Q3 25 | 16.2% | 2.7% | ||
| Q2 25 | 11.2% | 29.1% | ||
| Q1 25 | 6.5% | 3.2% | ||
| Q4 24 | — | 5.8% | ||
| Q3 24 | 25.2% | -41.2% | ||
| Q2 24 | -9.6% | -1.1% |
每股收益（稀释后）PBYIRMNI
| Q1 26 | — | $0.01 | ||
| Q4 25 | $0.26 | $0.00 | ||
| Q3 25 | $0.17 | $0.03 | ||
| Q2 25 | $0.12 | $0.32 | ||
| Q1 25 | $0.06 | $0.04 | ||
| Q4 24 | $0.40 | $0.07 | ||
| Q3 24 | $0.41 | $-0.47 | ||
| Q2 24 | $-0.09 | $-0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $132.2M |
| 总债务越低越好 | $22.7M | $56.4M |
| 股东权益账面价值 | $130.3M | — |
| 总资产 | $216.3M | $397.1M |
| 负债/权益比越低杠杆越低 | 0.17× | — |
8季度趋势，按日历期对齐
现金及短期投资PBYIRMNI
| Q1 26 | — | $132.2M | ||
| Q4 25 | $97.5M | $120.0M | ||
| Q3 25 | $94.4M | $108.7M | ||
| Q2 25 | $96.0M | $101.3M | ||
| Q1 25 | $93.2M | $122.6M | ||
| Q4 24 | $101.0M | $88.8M | ||
| Q3 24 | $96.7M | $119.5M | ||
| Q2 24 | $96.8M | $134.2M |
总债务PBYIRMNI
| Q1 26 | — | $56.4M | ||
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — |
股东权益PBYIRMNI
| Q1 26 | — | — | ||
| Q4 25 | $130.3M | $-27.0M | ||
| Q3 25 | $115.3M | $-27.3M | ||
| Q2 25 | $104.7M | $-29.0M | ||
| Q1 25 | $97.1M | $-63.7M | ||
| Q4 24 | $92.1M | $-69.4M | ||
| Q3 24 | $71.1M | $-76.8M | ||
| Q2 24 | $48.5M | $-36.1M |
总资产PBYIRMNI
| Q1 26 | — | $397.1M | ||
| Q4 25 | $216.3M | $423.1M | ||
| Q3 25 | $202.9M | $352.9M | ||
| Q2 25 | $194.9M | $397.5M | ||
| Q1 25 | $196.2M | $343.0M | ||
| Q4 24 | $213.3M | $369.1M | ||
| Q3 24 | $220.7M | $343.8M | ||
| Q2 24 | $205.0M | $367.4M |
负债/权益比PBYIRMNI
| Q1 26 | — | — | ||
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | — |
| 自由现金流经营现金流 - 资本支出 | $14.4M | — |
| 自由现金流率自由现金流/营收 | 19.1% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $41.7M | — |
8季度趋势，按日历期对齐
经营现金流PBYIRMNI
| Q1 26 | — | — | ||
| Q4 25 | $14.4M | $19.6M | ||
| Q3 25 | $9.7M | $24.7M | ||
| Q2 25 | $14.1M | $-17.8M | ||
| Q1 25 | $3.6M | $33.7M | ||
| Q4 24 | $15.6M | $-37.7M | ||
| Q3 24 | $11.0M | $-18.5M | ||
| Q2 24 | $1.0M | $6.3M |
自由现金流PBYIRMNI
| Q1 26 | — | — | ||
| Q4 25 | $14.4M | $18.9M | ||
| Q3 25 | $9.7M | $23.5M | ||
| Q2 25 | $14.1M | $-19.5M | ||
| Q1 25 | $3.6M | $32.8M | ||
| Q4 24 | $15.6M | $-38.4M | ||
| Q3 24 | $11.0M | $-19.2M | ||
| Q2 24 | $1.0M | $5.4M |
自由现金流率PBYIRMNI
| Q1 26 | — | — | ||
| Q4 25 | 19.1% | 17.2% | ||
| Q3 25 | 17.7% | 22.7% | ||
| Q2 25 | 26.8% | -18.8% | ||
| Q1 25 | 7.7% | 31.5% | ||
| Q4 24 | 26.4% | -33.6% | ||
| Q3 24 | 13.7% | -18.3% | ||
| Q2 24 | 2.1% | 5.2% |
资本支出强度PBYIRMNI
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 0.6% | ||
| Q3 25 | 0.0% | 1.2% | ||
| Q2 25 | 0.0% | 1.7% | ||
| Q1 25 | 0.1% | 0.9% | ||
| Q4 24 | 0.0% | 0.6% | ||
| Q3 24 | 0.0% | 0.6% | ||
| Q2 24 | 0.0% | 0.8% |
现金转化率PBYIRMNI
| Q1 26 | — | — | ||
| Q4 25 | — | 27.02× | ||
| Q3 25 | 1.10× | 8.94× | ||
| Q2 25 | 2.41× | -0.59× | ||
| Q1 25 | 1.21× | 10.06× | ||
| Q4 24 | — | -5.66× | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
